SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-031299
Filing Date
2024-07-05
Accepted
2024-07-05 17:18:33
Documents
10
Period of Report
2024-08-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A ginkgo-definitiveproxyspec.htm DEF 14A 280855
2 ginkgobioworksholdingsinc_.jpg GRAPHIC 514426
3 ginkgobioworksholdingsinc_a.jpg GRAPHIC 201002
4 icon-calendar.jpg GRAPHIC 22476
5 icon-internet.jpg GRAPHIC 115556
6 icon-locationpin.jpg GRAPHIC 1723
7 icon-phone.jpg GRAPHIC 100762
8 jasonkellysignature1080x10.jpg GRAPHIC 93481
9 karensig-proxy.jpg GRAPHIC 6952
10 qrcode.jpg GRAPHIC 7670
  Complete submission text file 0001628280-24-031299.txt   1747663
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40097 | Film No.: 241103067
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)